Combination of low-dose gemcitabine and recombinant quail vascular endothelial growth factor receptor-2 as a vaccine induces synergistic antitumor activities.

Source:http://linkedlifedata.com/resource/pubmed/id/16088235

Download in:

View as

General Info

PMID
16088235